Albany, NY -- (SBWIRE) -- 10/12/2016 -- Diabetes is a metabolic disease in which person has high blood glucose level due to inadequate insulin production or resistant of body cells to insulin. Majorly, diabetes is in three form: type 1 diabetes, type 2 diabetes, and gestational diabetes. In type 1 diabetes, body enable to secrete proper amount of insulin and also known as juvenile diabetes, insulin-dependent diabetes, and early-onset diabetes. About, 10% of all diabetes cases are type 1.

Request Sample of Research Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=8806

Insulin injections are necessary for the patient suffering from type 1 diabetes. Type 2 diabetes involves insulin resistance and gestational diabetes affects female during pregnancy due to less insulin production. However, type 2 and gestational diabetes can control by medication, exercise, and proper diet. Advancement in the insulin injection led to reusable and disposable pen injectors. Now a days, diabetic pens are preferable due to portability of pens, easy to take accurate dose, and convenient for injections.

Diabetes injection pens market majorly segmented based on usage of pens, and type of devices. Based on usage of pen the market further segmented into reusable insulin pen, and disposable insulin pen. Disposable pens are more convenient than the reusable pens. However, cost associated with disposable pen is more. Major brands of diabetes pen available in the U.S. market are Apidra SoloStar, Byetta, SymlinPen 60 & 120, Victoza, Humalog KwikPen, HumaPen LUXURA HD, Humulin Pen, Lantus Solostar, Levemir FlexPen, NovoLogMix FlexPen, NovoPen 3/ NovoPen Junior, and AutoPen.

Based on type of devices market is segmented into diabetic pens, and pen needles. Geographically, the global market segmented into North America, Europe, Asia Pacific, Latin America, Middle East Africa, and rest of the world. North America held largest market share of the global diabetes pen market in 2014 due to presence of major key players, growing early onset diabetic patient, and high health care expenditure ability. However, Asia Pacific is likely to grow at faster rate followed by Europe during forecast period due to growing awareness, huge diabetic population in asia, and increasing acceptance to diabetic pen.

Increasing diabetic patient globally is a major driving factor to boost the diabetic injection pens market. For instance, according to WHO globally prevalence of diabetes was 171 million in 2000 and is likely to reach at 366 million by 2030. In addition, the incidence of childhood onset type 1 diabetes in the under-15 age group is increasing in many countries in the world. According to International Diabetes Federation (IDF),annuallyabout 76,000 children aged below 15 years old develop type 1 diabetes worldwide. Additionally, convenient use, and avoid dependency on trained person for injection led to growing acceptance of diabetic injection pens in the market.

Advancement in the devices, decreasing price due to increasing competition, and growing awareness could further surge the market growth. For instance, in June 2013 Becton Dickson and Company launched Ultra-Fine Nano Pen Needle with EasyFlow Technology in the U.S. The pen needle is more convenient, higher flow rate with minimum leakage, and less painful. However, major reason to restraint the market growth is, pens are more expensive than syringes. Additionally, loss of one to two unit of insulin during each injection, non-availability of all types of insulin and mixture of insulin in pen form can negatively affect the market, albeit. Market opportunities are greatest in developing countries, as about 80% of all new cases of diabetes are expected to be reported in these countries by 2025.

Some of the major players in the global diabetes injection pens market are Novo Nordisk, Eli Lilly and Company, Medtronic, Becton Dickson and Company, Sanofi S.A., and F. Hoffman-La Roche AG.

About Transparency Market Research
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR's data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: 518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com